Novavax is a biotech company with a proven technology, focused on developing our R&D assets and establishing partnerships to help protect health.

May 20, 2025 · The Novavax vaccine is one of three vaccines available in the U.S. for the prevention of COVID-19 and the only one that does not use the relatively new mRNA vaccine …

The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, [1] among others, is a subunit COVID-19 vaccine developed by Novavax and the Coalition for …

May 18, 2025 · May 19, 2025 – The FDA has approved the Novavax COVID-19 vaccine, a protein-based alternative to mRNA shots, with some limits on who can get it.

On August 27, 2025, the Food and Drug Administration revoked the Emergency Use Authorization (EUA) for Novavax COVID-19 Vaccine, Adjuvanted. Nuvaxovid (COVID-19 Vaccine, …

Aug 27, 2025 · Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including …

Find the latest Novavax, Inc. (NVAX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Sep 10, 2024 · Novavax is a protein subunit vaccine and is based on a more traditional vaccination approach than mRNA vaccines. It contains a lab-made version of the SARS-CoV …

Dec 11, 2025 · Key Points Novavax faces plenty of uncertainty related to a deal it signed with a larger company. The biotech's pipeline doesn't look that exciting either.

Navigate global information about the authorization or approval status of the Novavax COVID-19 Vaccines worldwide.